A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01028495 |
|
Recruitment Status
:
Completed
First Posted
: December 9, 2009
Last Update Posted
: August 29, 2012
|
Sponsor:
Rexahn Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Rexahn Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 2012 |
| Actual Study Completion Date : | August 2012 |
Publications of Results:
Other Publications:
Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 3564
Other Publications: